These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 37489368)

  • 21. Immunotherapies against human bacterial and fungal infectious diseases: A review.
    Qadri H; Shah AH; Alkhanani M; Almilaibary A; Mir MA
    Front Med (Lausanne); 2023; 10():1135541. PubMed ID: 37122338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technological Evolution in the Development of Therapeutic Antibodies.
    Fajardo-Ramírez ÓR; Ascacio-Martínez JA; Licea-Navarro AF; Villela-Martínez LM; Barrera-Saldaña HA
    Rev Invest Clin; 2015; 67(3):158-69. PubMed ID: 26202739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB.
    Manso T; Kushwaha A; Abdollahi N; Duroux P; Giudicelli V; Kossida S
    Front Immunol; 2023; 14():1129323. PubMed ID: 37215135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.
    Mokhtary P; Pourhashem Z; Mehrizi AA; Sala C; Rappuoli R
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the Monoclonal Antibody Involvement in Targeting the Activation of Tumor Suppressor Genes.
    Mishra RK; Ahmad A; Vyawahare A; Kumar A; Khan R
    Curr Top Med Chem; 2020; 20(20):1810-1823. PubMed ID: 32543361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and molecular approaches to developing human monoclonal antibodies as drugs.
    Ren EC
    Ann Acad Med Singap; 1991 Jan; 20(1):66-70. PubMed ID: 2029167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of nucleic acid therapeutics for cancer immunotherapy.
    Zhou S; Chen W; Cole J; Zhu G
    Med Drug Discov; 2020 Jun; 6():. PubMed ID: 34337382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering humoral immunity as prophylaxis or therapy.
    Deal CE; Balazs AB
    Curr Opin Immunol; 2015 Aug; 35():113-22. PubMed ID: 26183209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Class of On-Treatment Cancer Immunotherapy Biomarker: Trough Levels of Antibody Therapeutics in Peripheral Blood.
    Koguchi Y; Redmond WL
    Immunol Invest; 2022 Nov; 51(8):2159-2175. PubMed ID: 36301695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation.
    Perez N; Bigey P; Scherman D; Danos O; Piechaczyk M; Pelegrin M
    Genet Vaccines Ther; 2004 Mar; 2(1):2. PubMed ID: 15038826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current issues of RNAi therapeutics delivery and development.
    Haussecker D
    J Control Release; 2014 Dec; 195():49-54. PubMed ID: 25111131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials.
    Heliopoulos I; Patousi A
    Med Chem; 2018 Feb; 14(2):144-154. PubMed ID: 28875861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications.
    Jones RG; Martino A
    Crit Rev Biotechnol; 2016; 36(3):506-20. PubMed ID: 25600465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and side effects of monoclonal antibodies.
    Hansel TT; Kropshofer H; Singer T; Mitchell JA; George AJ
    Nat Rev Drug Discov; 2010 Apr; 9(4):325-38. PubMed ID: 20305665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.
    Emmanuel SN; Smith JK; Hsi J; Tseng YS; Kaplan M; Mietzsch M; Chipman P; Asokan A; McKenna R; Agbandje-McKenna M
    J Virol; 2022 Feb; 96(3):e0125121. PubMed ID: 34757842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advancements in mRNA Encoded Antibodies for Passive Immunotherapy.
    Deal CE; Carfi A; Plante OJ
    Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33572679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.